Overview
The Irish Longitudinal Study on Ageing (TILDA) is a major inter-institutional initiative led by Trinity College Dublin (TCD) which aims to produce a massive improvement in the quantity and quality of data, research and information relating to older people and ageing in Ireland. It involves detailed interviews on a two yearly basis with a cohort of people aged 50 and over, charting their health, social and economic circumstances over a 10-year period. The study aims to determine: (1) the health, social and economic status and needs of older people, (2) the biological and environmental components of “successful ageing”, (3) the contributions that older people are making to society, and (4) how each of these key components interact and inform public health and social policy ensuring that Ireland meets the needs and choices of its citizens.
Data Collection
Wave 1 of TILDA was completed between October 2009 and February 2011 and collected data from a cohort of 8,504 respondents residing in the Republic of Ireland aged 50 years and over. Households were selected in geographic clusters from a list of all residential addresses in Ireland. Each selected household was visited by an interviewer and residents aged 50 or older, as well as their spouses or partners, were invited to participate. The household response rate was 62.0% (Whelan & Savva, 2013). Each respondent provided written informed consent. Those with cognitive impairments that prevented meaningful consent being given, were not included in the study. Respondents were interviewed in their homes by trained professional interviewers on many aspects of health, lifestyle, social interactions, and financial circumstances. They were also asked to answer a self-completion questionnaire (SCQ) and 85% returned the SCQ by post at wave 1. Each respondent was then invited to travel to one of two health centers, in Dublin and Cork, for a comprehensive health assessment or received a home health assessment; 72% of participants underwent a health assessment at wave 1. Venous blood (plasma and Buffy coats) from 69% of wave 1 participants was stored at -80oC at Trinity Biobank for future analytics. The sampling procedure, the home interview, and the health assessments have all been described in detail (Kearney et al., 2011a; Kearney et al., 2011b).
Wave 2 of TILDA was completed between February 2012 and March 2013 and included CAPI data from 7,375 self-respondents, a response rate of 88% of eligible and cognitively capable respondents, with 85% of these respondents returning an SCQ. This wave did not include a comprehensive health assessment. However, 97% of CAPI respondents performed the Timed Up and Go (TUG) and hand grip strength (baseline dynamometer reading on dominant hand) tests during the home interview.
Wave 3 of the study was completed between June 2014 and December 2015 and involved 6,566 self-respondents, a response rate of 85%, with 85% of these returning an SCQ. All participants at wave 3 were invited to undergo a health assessment, which was either a full assessment at a center in Dublin, or a partial assessment in their own homes; 81% of participants underwent a comprehensive health assessment. The various clinical measurements taken at the health center were repeated from wave 1 with the inclusion of some new additional function and performance tests. Venous blood (whole blood, plasma and Buffy coat) from 75% of wave 3 participants was stored at -80oC at Trinity Biobank for future analytics. PAXgene RNA blood samples were also collected from 874 participants and stored at -80oC for future analyses at wave 3.
Wave 4 of TILDA was completed between January and December 2016 and included 5,856 self-respondents, a response rate of 84%, with 86% of these returning an SCQ. This wave did not include a comprehensive health assessment. However, 91% of CAPI respondents performed the Timed Up and Go (TUG) and 95% performed the hand grip strength (baseline dynamometer reading on dominant hand) test during the home interview.
Wave 5 of TILDA was completed between March and December 2018 and included 5,103 self-respondents, a response rate of 84%, with 86% of these returning an SCQ. This wave did not include a comprehensive health assessment. However 89% of CAPI respondents performed the Timed Up and Go (TUG) and 91% performed the hand grip strength (baseline dynamometer reading on dominant hand) test during the home interview.
Wave 6 (2020) will be undertaken in 2020. This wave will incorporate the CAPI, SCQ and a comprehensive health assessment. A replenishment of the TILDA cohort will also be undertaken with a target recruitment sample of 2,000 respondents aged 50-59 years.
Biomarkers
TILDA biomarker data collection was undertaken during the comprehensive health assessments at Wave 1 and 3. The Timed Up and Go (TUG) and hand grip strength (baseline dynamometer reading on dominant hand) were assessed during the home interviews at waves 2, 4 and 5.
The biomarkers collected to date are outlined in Tables1 and 2. TILDA has been designed such that many biomarkers map onto similar international studies of older adults such as the Health and Retirement Study (HRS), the Survey of Health, Ageing and Retirement in Europe (SHARE) and the English Longitudinal Study of Ageing (ELSA).
Publications
A description of the TILDA cohort profile is available in the following publications:
Donoghue, O. A., McGarrigle, C. A., Foley, M., Fagan, A., Meaney, J., & Kenny, R. A. (2018). Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA). International journal of epidemiology, 47(5), 1398-1398l.
Kearney, P. M., Cronin, H., O’regan, C., Kamiya, Y., Savva, G. M., Whelan, B., & Kenny, R. (2011). Cohort profile: the Irish longitudinal study on ageing. International journal of epidemiology, 40 (4), 877-884.
Data Access
Table 1. Tests included in the TILDA health assessment at each health wave | |
Neuropsychological function | Gait and mobility |
Mini-Mental State Examination (MMSE)1,a | Timed up-and-go (TUG)1,3,d |
Montreal Cognitive Assessment (MOCA)1,3 | Repeated chair stands3 |
Sustained Attention to Response Task (SART)1,3 | GAITRite assessment |
Picture memory test1 | – normal pace1,3,c |
National Adult Reading Test (NART)3 | – dual task (manual)1,c |
Visual reasoning1 | – dual task (cognitive)1,3,c |
Choice reaction time1,3 | – maximum pace3,c |
Colour trails test1,3 | |
Centre for Epidemiological Studies Depression (CES-D) 8-item scale1,3,b | Blood Biomarkers1,3 |
State trait anxiety inventory3 | Lipid profile1,3 |
HbA1c1,3 | |
Cardiovascular function | C-reactive protein1 |
Blood pressure (Omron)1,3 | Creatinine1 |
Pulse wave velocity1,3,c | Cystatin C1 |
Heart rate variability1,3,c | Folate1 |
Phasic blood pressure1,3,c | Vitamin B121 |
Near-infrared spectroscopy (NIRS)3,c | Vitamin D1 |
Lutein1 | |
Sensory function | Zeaxanthin1 |
Visual acuity1,3,c | Interluekin-181e |
Contrast sensitivity1,3,c | Complement Factor 31e |
Macular pigment optical density1,c | |
Retinal photograph1,3,c | Hair sample3 |
Sound-induced flash illusion (SHAMS)3,c | Cortisol3 |
Cortisone3 | |
Physical Activity | Testosterone3 |
Physical activity question3,c | Progesterone3 |
Accelerometry3,g | Dehydroepiandrosterone3 |
Other | Genetics/Genomics |
Oral health3,c,g | Genomic DNA extracted1 |
MRI3,c,e | 7 Age-related Macular Degeneration candidate SNPs genotyped1 |
12 Blood pressure SNPs genotyped1 | |
Anthropometrics | |
Grip strength1,3,d | Epigenetics |
Height1,3 | DNA methylation 1,e |
Weight1,3 | |
Waist and hip circumference1,3 | Transcriptomics |
PAXgene RNA Blood Tubes3,e | |
Bone health | |
Heel bone ultrasound1,3,c | |
1,3 Indicate the wave in which data were collected (i.e. Wave 1, Wave 3).
a MMSE was included in Waves 2, 3 and 4 CAPI.
b CESD-20 was included in Waves 1 and 2 CAPI; CESD-8 was included in Waves 3 and 4 CAPI.
c Included in the health centre assessment only.
dTUG and grip strength were included in Waves 2, 4 and 5 CAPI.
e Included for a sub-study only, due to resource availability (i.e. limited accelerometers, availability of dentist, limited MRI funding).